hydrogen sulfide has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Deng, H; Feng, J; Guo, R; Lin, J; Lin, K; Liu, D; Wu, W; Zhang, W; Zhi, X | 1 |
1 other study(ies) available for hydrogen sulfide and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Exogenous hydrogen sulfide protects human umbilical vein endothelial cells against high glucose‑induced injury by inhibiting the necroptosis pathway.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase 3; Cytoprotection; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Sulfide; Imidazoles; Indoles; Membrane Potential, Mitochondrial; Necrosis; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Up-Regulation | 2018 |